PRAX vs PRU · $7.38B cap vs rev $31.19B
Praxis Precision Medicines Inc (PRAX) versus PRU (PRU) — a side-by-side from cached financials, not a winner call.
Praxis Precision Medicines Inc (PRAX) is a biotechnology company listed on US.
PRU (PRU) common stock.
Latest reported PRAX revenue for 2025-09-30 was $0. Net income was -$73.9M. PRAX currently screens at market cap $7.38B.
Latest reported PRU revenue for 2026-06-30 was $31.19B. Net income was $1.58B. PRU currently screens at market cap $0.
PRAX currently screens at market cap $7.38B. PRU currently screens at market cap $0.
Not investment advice. Open the PRAX and PRU stock pages for the full models.
Not investment advice.